Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475063 | 1.00 | CNR2 (0.69) | CNR2CNR1 | |
| SCHEMBL475065 | 1.00 | CNR2 (0.69) | CNR2CNR1 | |
| SCHEMBL476002 | 0.89 | CNR2 (0.65) | CNR2CNR1 | |
| SCHEMBL476003 | 0.89 | CNR2 (0.65) | CNR2CNR1 | |
| SCHEMBL284289 | 0.87 | CNR2 (0.72) | CNR2CNR1 | |
| SCHEMBL2813375 | 0.87 | CNR2 (0.72) | CNR2CNR1 | |
| SCHEMBL475985 | 0.87 | CNR2 (0.62) | CNR2CNR1 | |
| SCHEMBL475987 | 0.87 | CNR2 (0.62) | CNR2CNR1 | |
| SCHEMBL328667 | 0.86 | CNR2 (0.71) | CNR2CNR1 | |
| SCHEMBL475190 | 0.86 | CNR2 (0.71) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411370-B1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBVIE INC (US) | 2015-04-22 | — | — | EP | disclosed |
| US-8288428-B2 | Compounds as cannabinoid receptor ligands | ABBOTT LABORATORIES (US) | 2012-10-16 | — | — | US | disclosed |
| US-20100249087-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249087-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | CNR1, CNR2, GPR18 | CNR2 2/4885CNR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.